1230448

Xttrium Laboratories, Inc. — FEI 3008436464

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 6, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mount Prospect, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)